Benzodiazepines and anticholinergic drugs are common classes of medications. Doctors already knew that some of their side effects were memory and confusion, but research suggests it can be much worse.
A SECOND “game-changing” Alzheimer’s drug shown to slow the progression of the disease has been approved in the UK. Donanemab, developed by pharmaceutical giant Eli Lilly, was ...